Cerecin strengthens position in neurometabolism with addition to pipeline
- Written by PR Newswire
![]() |
- Cerecin completes in-licensing of an investigational radiolabelled tracer 18FBHB, CER-022, for development and use in positron emission tomography (PET) studies of ketone body metabolism
- Company expands ketogenic platform following pilot data of CER-0001 in migraine and infantile spasms.
- CER-022 is a novel diagnostic asset with potential...
Read more: Cerecin strengthens position in neurometabolism with addition to pipeline